2 p.m. ET Wednesday, July 19
The most recent screening guidelines from the U.S. Preventive Services Task Force are controversial and confusing. Journalists must report responsibly on the latest health recommendations while talking about cancer — a subject that is often emotionally charged — using the latest scientific evidence.
At this webinar, experts will suggest approaches to putting the latest screening recommendations in context while eliminating hype and not creating false hope.
Mehra Golshan, M.D.
Elaine Schattner, M.D.
Liz Seegert
Tara HaelleMehra Golshan, M.D., is a cancer surgeon and a nationally and internationally recognized leader in breast cancer treatment and research. He serves as deputy chief medical officer for surgical services and as clinical director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center. He has led numerous Phase I, II and III clinical trials and translational science innovations that have had an impact on treatment options and outcomes for women. Dr. Golshan is also a leading researcher in this field, with over 150 peer-reviewed publications.
Elaine Schattner, M.D., is a writer, breast cancer survivor, and physician. A graduate of Yale College and New York University School of Medicine, she is a clinical associate professor at Weill Cornell Medicine in the division of hematology and medical oncology. She worked as an oncologist for 16 years before completing a master’s degree in journalism at Columbia University. Her articles have appeared in the New York Observer, Huffington Post, Pacific Standard, Washington Post, NPR, and elsewhere. Her new book, “From Whispers to Shouts: The Ways We Talk About Cancer” is published by Columbia University Press.